Long-Term Combined Training in Idiopathic Pulmonary Fibrosis: A Case Study

被引:7
作者
Naranjo-Orellana, Jose [1 ]
Santalla, Alfredo [1 ,2 ]
机构
[1] Pablo de Olavide Univ, Dept Sport & Comp, Seville 41013, Spain
[2] Inst Invest Hosp 12 Octubre I 12, Madrid 28041, Spain
关键词
inspiratory muscle training; resistance training; idiopathic pulmonary fibrosis; LUNG TRANSPLANTATION; INSPIRATORY MUSCLE; VENTILATORY EFFICIENCY; ARTERIAL-HYPERTENSION; EXERCISE CAPACITY; PHYSICAL-ACTIVITY; REHABILITATION; BENEFITS; OUTCOMES;
D O I
10.3390/ijerph17145091
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
A supervised combined training program was applied to a sedentary 56-year-old man with idiopathic pulmonary fibrosis (IPF) along three years, until lung transplantation. It included: (a) aerobic continuous (CT) and interval training (IT), (b) high load resistance training (RT) and (c) inspiratory muscle training (IMT). IT and IMT were applied for two years, while CT and RT could be maintained until transplantation using supplemental oxygen. Maximal inspiratory pressure (MIP) kept above 180 cm H2O and forced vital capacity (FVC) remained stable until lung transplantation. Peak oxygen uptake VO(2)increased during 1.5 years before its decline, staying above the poor prognosis level two years. Finally, the patient maintained his walking capacity and independence for 2 years, before the decline due to the disease. After receiving a two-lung transplant, the patient remained intubated for 12 h, left the intensive care unit after 3.5 days and was discharged after 18 days (average values: 48 h, 7-10 days and 25-35 days, respectively). These results show that systematic and supervised combined training can be safety applied in an IPF patient to maintain functionality and quality of life. In addition, we show that RT can be maintained for as long as necessary without complications.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 50 条
  • [31] Adherence, Persistence, and Effectiveness in Real Life. Multicenter Long-Term Study on the Use of Pirfenidone and Nintedanib in the Treatment of Idiopathic Pulmonary Fibrosis
    Santoleri, Fiorenzo
    Auriemma, Luigia
    Spacone, Antonella
    Marinari, Stefano
    Esposito, Fabio
    De Vita, Francesco
    Petragnani, Giovanni
    Di Fabio, Caterina
    Di Fabio, Letizia
    Costantini, Alberto
    JOURNAL OF PHARMACY PRACTICE, 2022, 35 (06) : 853 - 858
  • [32] Multi-institutional prospective cohort study of prognostic factors in patients with idiopathic pulmonary fibrosis receiving long-term oxygen therapy
    Kataoka, Kensuke
    Oda, Keishi
    Takizawa, Hajime
    Ogura, Takashi
    Miyamoto, Atsushi
    Sekiguchi, Mutsumi
    Akagawa, Shinobu
    Hashimoto, Seishu
    Kishaba, Tomoo
    Hasegawa, Yoshinori
    Hamada, Naoki
    Kuwano, Kazuyoshi
    Nakayama, Masayuki
    Ebina, Masahito
    Enomoto, Noriyuki
    Miyazaki, Yasunari
    Atsumi, Kenichiro
    Izumi, Shinyu
    Tanino, Yoshinori
    Ishii, Hiroshi
    Ohnishi, Hiroshi
    Kondoh, Yasuhiro
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [33] Long-term tolerability of real-life use of antifibrotic agents (AFA) in Idiopathic Pulmonary Fibrosis (IPF)
    Strens, Danielle
    Bondue, Benjamin
    Dahlqvist, Caroline
    Slabbynck, Hans
    Guiot, Julien
    Joos, Guy
    Gusbin, Natacha
    Wirtz, Gil
    Froidure, Antoine
    Wuyts, Wim
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [34] Short- and Long-Term Reliability of the 6-Minute Walk Test in People With Idiopathic Pulmonary Fibrosis
    Holland, Anne E.
    Hill, Catherine J.
    Dowman, Leona
    Glaspole, Ian
    Goh, Nicole
    Lee, Annemarie L.
    McDonald, Christine F.
    RESPIRATORY CARE, 2018, 63 (08) : 994 - 1001
  • [35] Comparison of clinical characteristics and prognostic factors of combined pulmonary fibrosis and emphysema versus idiopathic pulmonary fibrosis alone
    Sugino, Keishi
    Ishida, Fumiaki
    Kikuchi, Naoshi
    Hirota, Nao
    Sano, Go
    Sato, Keita
    Isobe, Kazutoshi
    Sakamoto, Susumu
    Takai, Yujiro
    Homma, Sakae
    RESPIROLOGY, 2014, 19 (02) : 239 - 245
  • [36] Histological analysis of vasculopathy associated with pulmonary hypertension in combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis or emphysema alone
    Awano, Nobuyasu
    Inomata, Minoru
    Ikushima, Soichiro
    Yamada, Daisuke
    Hotta, Masatoshi
    Tsukuda, Shunji
    Kumasaka, Toshio
    Takemura, Tamiko
    Eishi, Yoshinobu
    HISTOPATHOLOGY, 2017, 70 (06) : 896 - 905
  • [37] Stratification of long-term outcome in stable idiopathic pulmonary fibrosis by combining longitudinal computed tomography and forced vital capacity
    Nicola Sverzellati
    Mario Silva
    Valeria Seletti
    Carlotta Galeone
    Stefano Palmucci
    Sara Piciucchi
    Carlo Vancheri
    Venerino Poletti
    Sara Tomassetti
    Ronald Karwoski
    Brian J. Bartholmai
    European Radiology, 2020, 30 : 2669 - 2679
  • [38] Stratification of long-term outcome in stable idiopathic pulmonary fibrosis by combining longitudinal computed tomography and forced vital capacity
    Sverzellati, Nicola
    Silva, Mario
    Seletti, Valeria
    Galeone, Carlotta
    Palmucci, Stefano
    Piciucchi, Sara
    Vancheri, Carlo
    Poletti, Venerino
    Tomassetti, Sara
    Karwoski, Ronald
    Bartholmai, Brian J.
    EUROPEAN RADIOLOGY, 2020, 30 (05) : 2669 - 2679
  • [39] Subtypes of pulmonary emphysema on HRCT affect prognosis on combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis
    Shiratori, Masanori
    Yokoo, Keiki
    Ikeda, Kimiyuki
    Natsuizaka, Motoki
    Umeda, Yasuaki
    Kitamura, Yasuo
    Otsuka, Mitsuo
    Chiba, Hirofumi
    Koba, Hiroyuki
    Takahashi, Hiroki
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [40] Idiopathic Pulmonary Fibrosis: A Case of Mistaken Identity
    Miskoff, Jeffrey A.
    Chaudhri, Moiuz
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (11)